胎儿生长受限的临床预防与管理
Clinical Prevention and Management of Fetal Growth Restriction
DOI: 10.12677/jcpm.2025.44417, PDF,   
作者: 刘雅洁, 张嘉悦：西安医学院研究生工作部，陕西 西安；董 晋*：西北妇女儿童医院产科，陕西 西安
关键词: 胎儿生长受限；超声；管理；Fetal Growth Restriction； Ultrasound； Management
摘要: 胎儿生长受限(Fetal Growth Restriction, FGR)是导致围产儿死亡的第二大主要原因，对胎儿的近期健康及长期预后均产生显著不良影响。随着现代产前诊断技术的快速发展和对FGR发病机制认识的不断深入，其临床诊断和治疗方案已取得显著进展。然而，目前尚缺乏能够有效改善胎盘功能或促进胎儿体重增长的治疗手段。本文系统综述了FGR的定义标准、临床管理策略及预防措施，以期为临床决策提供循证依据，并探讨该领域未来的研究方向。
Abstract: Fetal Growth Restriction (FGR) is the second leading cause of perinatal mortality and has significant adverse effects on both the immediate health and long-term prognosis of the fetus. With the rapid development of modern prenatal diagnostic techniques and a deeper understanding of the pathogenesis of FGR, notable progress has been made in its clinical diagnosis and treatment strategies. However, there is still a lack of effective therapeutic interventions to improve placental function or promote fetal weight gain. This article systematically reviews the diagnostic criteria, clinical management strategies, and preventive measures for FGR, aiming to provide evidence-based support for clinical decision-making and explore future research directions in this field.
文章引用：刘雅洁, 张嘉悦, 董晋. 胎儿生长受限的临床预防与管理[J]. 临床个性化医学, 2025, 4(4): 64-69. https://doi.org/10.12677/jcpm.2025.44417

参考文献

[1] 王昊, 漆洪波. 全球胎儿生长受限指南: 求同存异[J]. 中华围产医学杂志, 2024, 27(9): 710-721.
[2] 王雅慧, 王艳, 王艳, 等. 胎儿生长受限的病因及对患儿远期健康的影响[J]. 国际妇产科学杂志, 2024, 51(2): 152-156.
[3] Jarvis, S., Glinianaia, S.V., Torrioli, M., Platt, M., Miceli, M., Jouk, P., et al. (2003) Cerebral Palsy and Intrauterine Growth in Single Births: European Collaborative Study. The Lancet, 362, 1106-1111. [Google Scholar] [CrossRef] [PubMed]
[4] Bose, C., Van Marter, L.J., Laughon, M., O'Shea, T.M., Allred, E.N., Karna, P., et al. (2009) Fetal Growth Restriction and Chronic Lung Disease among Infants Born before the 28th Week of Gestation. Pediatrics, 124, e450-e458. [Google Scholar] [CrossRef] [PubMed]
[5] Tröger, B., Göpel, W., Faust, K., Müller, T., Jorch, G., Felderhoff-Müser, U., et al. (2014) Risk for Late-Onset Blood-Culture Proven Sepsis in Very-Low-Birth Weight Infants Born Small for Gestational Age. Pediatric Infectious Disease Journal, 33, 238-243. [Google Scholar] [CrossRef] [PubMed]
[6] Mukhopadhyay, D., Weaver, L., Tobin, R., Henderson, S., Beeram, M., Newell-Rogers, M.K., et al. (2014) Intrauterine Growth Restriction and Prematurity Influence Regulatory T Cell Development in Newborns. Journal of Pediatric Surgery, 49, 727-732. [Google Scholar] [CrossRef] [PubMed]
[7] Barker, D.J.P. (2006) Adult Consequences of Fetal Growth Restriction. Clinical Obstetrics and Gynecology, 49, 270-283. [Google Scholar] [CrossRef] [PubMed]
[8] Banister, C.E., Koestler, D.C., Maccani, M.A., Padbury, J.F., Houseman, E.A. and Marsit, C.J. (2011) Infant Growth Restriction Is Associated with Distinct Patterns of DNA Methylation in Human Placentas. Epigenetics, 6, 920-927. [Google Scholar] [CrossRef] [PubMed]
[9] Murray, E., Fernandes, M., Fazel, M., Kennedy, S., Villar, J. and Stein, A. (2015) Differential Effect of Intrauterine Growth Restriction on Childhood Neurodevelopment: A Systematic Review. BJOG: An International Journal of Obstetrics & Gynaecology, 122, 1062-1072. [Google Scholar] [CrossRef] [PubMed]
[10] Bickle Graz, M., Tolsa, J. and Fischer Fumeaux, C.J. (2015) Being Small for Gestational Age: Does It Matter for the Neurodevelopment of Premature Infants? A Cohort Study. PLOS ONE, 10, e0125769. [Google Scholar] [CrossRef] [PubMed]
[11] Korzeniewski, S.J., Allred, E.N., Joseph, R.M., Heeren, T., Kuban, K.C.K., O’Shea, T.M., et al. (2017) Neurodevelopment at Age 10 Years of Children Born < 28 Weeks with Fetal Growth Restriction. Pediatrics, 140, e20170697. [Google Scholar] [CrossRef] [PubMed]
[12] Baschat, A.A. (2013) Neurodevelopment after Fetal Growth Restriction. Fetal Diagnosis and Therapy, 36, 136-142. [Google Scholar] [CrossRef] [PubMed]
[13] Ota, E., Tobe-Gai, R., Mori, R., et al. (2025) Antenatal Dietary Advice and Supplementation to Increase Energy and Protein Intake. Cochrane Library.
[14] Garner, P. and Gülmezoglu, A.M. (2006) Drugs for Preventing Malaria in Pregnant Women. The Cochrane Database of Systematic Reviews, 4, CD000169.
[15] Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N. and Bujold, E. (2017) The Role of Aspirin Dose on the Prevention of Preeclampsia and Fetal Growth Restriction: Systematic Review and Meta-Analysis. American Journal of Obstetrics and Gynecology, 216, 110-120.e6. [Google Scholar] [CrossRef] [PubMed]
[16] Yinon, Y., Ben Meir, E., Margolis, L., Lipitz, S., Schiff, E., Mazaki-Tovi, S., et al. (2015) Low Molecular Weight Heparin Therapy during Pregnancy Is Associated with Elevated Circulatory Levels of Placental Growth Factor. Placenta, 36, 121-124. [Google Scholar] [CrossRef] [PubMed]
[17] Pusayapaibul, P., Manonai, J. and Tangshewinsirikul, C. (2022) Factors Influencing Parental Decisions to Terminate Pregnancies Following Prenatal Diagnoses of Major Fetal Anomalies at Ramathibodi Hospital, Bangkok, Thailand. BMC Pregnancy and Childbirth, 22, Article No. 480. [Google Scholar] [CrossRef] [PubMed]
[18] Caradeux, J., Martinez-Portilla, R.J., Peguero, A., Sotiriadis, A. and Figueras, F. (2019) Diagnostic Performance of Third-Trimester Ultrasound for the Prediction of Late-Onset Fetal Growth Restriction: A Systematic Review and Meta-Analysis. American Journal of Obstetrics and Gynecology, 220, 449-459. [Google Scholar] [CrossRef] [PubMed]
[19] Figueras, F., Caradeux, J., Crispi, F., Eixarch, E., Peguero, A. and Gratacos, E. (2018) Diagnosis and Surveillance of Late-Onset Fetal Growth Restriction. American Journal of Obstetrics and Gynecology, 218, S790-S802. [Google Scholar] [CrossRef] [PubMed]
[20] Roma, E., Arnau, A., Berdala, R., Bergos, C., Montesinos, J. and Figueras, F. (2015) Ultrasound Screening for Fetal Growth Restriction at 36-vs-32 Weeks’ Gestation: A Randomized Trial (Route). Ultrasound in Obstetrics & Gynecology, 46, 391-397. [Google Scholar] [CrossRef] [PubMed]
[21] Rizzo, G., Mappa, I., Bitsadze, V., Słodki, M., Khizroeva, J., Makatsariya, A., et al. (2020) Role of Doppler Ultrasound at Time of Diagnosis of Late‐onset Fetal Growth Restriction in Predicting Adverse Perinatal Outcome: Prospective Cohort Study. Ultrasound in Obstetrics & Gynecology, 55, 793-798. [Google Scholar] [CrossRef] [PubMed]
[22] (2021) Fetal Growth Restriction: ACOG Practice Bulletin, Number 227. Obstetrics and Gynecology, 137, e16-e28.
[23] Greer, I.A. and Nelson-Piercy, C. (2005) Low-Molecular-Weight Heparins for Thromboprophylaxis and Treatment of Venous Thromboembolism in Pregnancy: A Systematic Review of Safety and Efficacy. Blood, 106, 401-407. [Google Scholar] [CrossRef] [PubMed]
[24] Olofsson, P. (2023) Umbilical Cord pH, Blood Gases, and Lactate at Birth: Normal Values, Interpretation, and Clinical Utility. American Journal of Obstetrics and Gynecology, 228, S1222-S1240. [Google Scholar] [CrossRef] [PubMed]